131 related articles for article (PubMed ID: 27568036)
1. Time-delayed contrast-enhanced MRI improves detection of brain metastases: a prospective validation of diagnostic yield.
Cohen-Inbar O; Xu Z; Dodson B; Rizvi T; Durst CR; Mukherjee S; Sheehan JP
J Neurooncol; 2016 Dec; 130(3):485-494. PubMed ID: 27568036
[TBL] [Abstract][Full Text] [Related]
2. Time-delayed contrast-enhanced MRI improves detection of brain metastases and apparent treatment volumes.
Kushnirsky M; Nguyen V; Katz JS; Steinklein J; Rosen L; Warshall C; Schulder M; Knisely JP
J Neurosurg; 2016 Feb; 124(2):489-95. PubMed ID: 26361281
[TBL] [Abstract][Full Text] [Related]
3. Magnetic resonance evaluation of brain metastases from systemic malignances with two doses of gadobutrol 1.0 m compared with gadoteridol: a multicenter, phase ii/iii study in patients with known or suspected brain metastases.
Katakami N; Inaba Y; Sugata S; Tsurusaki M; Itoh T; Machida T; Tanaka H; Nakayama T; Morikawa T; Breuer J; Aitoku Y
Invest Radiol; 2011 Jul; 46(7):411-8. PubMed ID: 21467949
[TBL] [Abstract][Full Text] [Related]
4. Reducing false positives in deep learning-based brain metastasis detection by using both gradient-echo and spin-echo contrast-enhanced MRI: validation in a multi-center diagnostic cohort.
Yun S; Park JE; Kim N; Park SY; Kim HS
Eur Radiol; 2024 May; 34(5):2873-2884. PubMed ID: 37891415
[TBL] [Abstract][Full Text] [Related]
5. Delayed contrast extravasation MRI: a new paradigm in neuro-oncology.
Zach L; Guez D; Last D; Daniels D; Grober Y; Nissim O; Hoffmann C; Nass D; Talianski A; Spiegelmann R; Tsarfaty G; Salomon S; Hadani M; Kanner A; Blumenthal DT; Bukstein F; Yalon M; Zauberman J; Roth J; Shoshan Y; Fridman E; Wygoda M; Limon D; Tzuk T; Cohen ZR; Mardor Y
Neuro Oncol; 2015 Mar; 17(3):457-65. PubMed ID: 25452395
[TBL] [Abstract][Full Text] [Related]
6. Brain metastases--comparison of gadodiamide injection-enhanced MR imaging at standard and high dose, contrast-enhanced CT and non-contrast-enhanced MR imaging.
Akeson P; Larsson EM; Kristoffersen DT; Jonsson E; Holtås S
Acta Radiol; 1995 May; 36(3):300-6. PubMed ID: 7742127
[TBL] [Abstract][Full Text] [Related]
7. Multicontrast single-slab 3D MRI to detect cerebral metastasis.
Chen W; Wang L; Zhu W; Xia L; Qi J; Feng D; Luo X
AJR Am J Roentgenol; 2012 Jan; 198(1):27-32. PubMed ID: 22194476
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic Performance of MRI Sequences for Evaluation of Dural Venous Sinus Thrombosis.
Sadigh G; Mullins ME; Saindane AM
AJR Am J Roentgenol; 2016 Jun; 206(6):1298-306. PubMed ID: 27010526
[TBL] [Abstract][Full Text] [Related]
9. An assessment of the effectiveness of magnetic resonance imaging in delayed sequences after administration of Gd-DTPA contrast in the detection of metastatic lesions in the brain.
Grzesiakowska U; Tacikowska M
Med Sci Monit; 2002 Jan; 8(1):MT21-4. PubMed ID: 11782684
[TBL] [Abstract][Full Text] [Related]
10. Optimizing contrast-enhanced magnetic resonance imaging characterization of brain metastases: relevance to stereotactic radiosurgery.
Anzalone N; Essig M; Lee SK; Dörfler A; Ganslandt O; Combs SE; Picozzi P
Neurosurgery; 2013 May; 72(5):691-701. PubMed ID: 23381488
[TBL] [Abstract][Full Text] [Related]
11. Optimizing intracranial metastasis detection for stereotactic radiosurgery.
Engh JA; Flickinger JC; Niranjan A; Amin DV; Kondziolka DS; Lunsford LD
Stereotact Funct Neurosurg; 2007; 85(4):162-8. PubMed ID: 17259753
[TBL] [Abstract][Full Text] [Related]
12. Dynamic contrast-enhanced MRI of prostate cancer at 3 T: a study of pharmacokinetic parameters.
Ocak I; Bernardo M; Metzger G; Barrett T; Pinto P; Albert PS; Choyke PL
AJR Am J Roentgenol; 2007 Oct; 189(4):849. PubMed ID: 17885055
[TBL] [Abstract][Full Text] [Related]
13. Mangafodipir trisodium (MnDPDP)-enhanced magnetic resonance imaging of the liver and pancreas.
Wang C
Acta Radiol Suppl; 1998; 415():1-31. PubMed ID: 9571956
[TBL] [Abstract][Full Text] [Related]
14. Radiotherapy of liver metastases. Comparison of target volumes and dose-volume histograms employing CT- or MRI-based treatment planning.
Pech M; Mohnike K; Wieners G; Bialek E; Dudeck O; Seidensticker M; Peters N; Wust P; Gademann G; Ricke J
Strahlenther Onkol; 2008 May; 184(5):256-61. PubMed ID: 18427756
[TBL] [Abstract][Full Text] [Related]
15. [Diagnostic evaluation of chronic inflammatory intestinal diseases in children and adolescents: MRI with true-FISP as new gold standard?].
Hohl C; Haage P; Krombach GA; Schmidt T; Ahaus M; Günther RW; Staatz G
Rofo; 2005 Jun; 177(6):856-63. PubMed ID: 15902636
[TBL] [Abstract][Full Text] [Related]
16. Progressive increase of T1 signal intensity of the dentate nucleus on unenhanced magnetic resonance images is associated with cumulative doses of intravenously administered gadodiamide in patients with normal renal function, suggesting dechelation.
Errante Y; Cirimele V; Mallio CA; Di Lazzaro V; Zobel BB; Quattrocchi CC
Invest Radiol; 2014 Oct; 49(10):685-90. PubMed ID: 24872007
[TBL] [Abstract][Full Text] [Related]
17. Malignancy assessment of brain tumours with magnetic resonance spectroscopy and dynamic susceptibility contrast MRI.
Fayed N; Dávila J; Medrano J; Olmos S
Eur J Radiol; 2008 Sep; 67(3):427-33. PubMed ID: 18442889
[TBL] [Abstract][Full Text] [Related]
18. Comparison of contrast-enhanced T1-weighted FLAIR with BLADE, and spin-echo T1-weighted sequences in intracranial MRI.
Alkan O; Kizilkiliç O; Yildirim T; Alibek S
Diagn Interv Radiol; 2009 Jun; 15(2):75-80. PubMed ID: 19517375
[TBL] [Abstract][Full Text] [Related]
19. Comparison between two separate injections and a single injection of double-dose contrast medium for contrast-enhanced MR imaging of metastatic brain tumors.
Ochi T; Taoka T; Matsuda R; Sakamoto M; Akashi T; Tamamoto T; Sugimoto T; Sakaguchi H; Hasegawa M; Nakase H; Kichikawa K
Magn Reson Med Sci; 2014; 13(4):221-9. PubMed ID: 25167875
[TBL] [Abstract][Full Text] [Related]
20. Screening for brain metastases in patients with stage III non-small cell lung cancer: Is there additive value of magnetic resonance imaging above a contrast-enhanced computed tomography of the brain?
Hendriks LE; Bootsma GP; de Ruysscher DK; Scheppers NA; Hofman PA; Brans BT; Dingemans AM
Lung Cancer; 2013 Jun; 80(3):293-7. PubMed ID: 23518381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
